Global PD-1 and PD-L1 Inhibitors Industry Research Report 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The PD-1 and PD-L1 Inhibitors market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for PD-1 and PD-L1 Inhibitors is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of PD-1 and PD-L1 Inhibitors industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading PD-1 and PD-L1 Inhibitors by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global PD-1 and PD-L1 Inhibitors market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The PD-1 and PD-L1 Inhibitors market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for PD-1 and PD-L1 Inhibitors is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of PD-1 and PD-L1 Inhibitors industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading PD-1 and PD-L1 Inhibitors by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global PD-1 and PD-L1 Inhibitors market are discussed.
The market is segmented by types:
- K Drugs
- O Drugs
- T Drugs
- B Drugs
- I Drugs
- Gastric Tumor
- Colorectal Cancer
- Hodgkin'S Lymphoma
- Non-Small Cell Lung Cancer
- Urothelial Carcinoma
- Renal Cell Carcinoma
- Hepatoma
- Other
Finally, the report provides detailed profile and data information analysis of leading company.
- Merck
- Tesaro
- AstraZeneca
- Pfizer
- Biocad
- Roche
- Boehringer Ingelheim
- Novartis
- Bristol-Myers Squibb
- Johnson & Johnson
- Beigene
- ALPHAMAB ONCOLOGY
- CytomX
- Harbin Gloria Pharmaceuticals
- Genor Biopharma
- Innovent Biologics
- Shanghai Junshi Biosciences
- 3D Medicines
- Zhaoke Pharmaceutical
- Jiangsu Hengrui Medicine
- WuXi AppTec
- xx data tables and xx additional tables
- An overview of global PD-1 and PD-L1 Inhibitors market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the PD-1 and PD-L1 Inhibitors market
- Profiles of major players in the industry, including Merck, Tesaro, AstraZeneca, Pfizer, Biocad.....
- To study and analyze the global PD-1 and PD-L1 Inhibitors consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of PD-1 and PD-L1 Inhibitors market by identifying its various subsegments.
- Focuses on the key global PD-1 and PD-L1 Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the PD-1 and PD-L1 Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of PD-1 and PD-L1 Inhibitors submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global PD-1 and PD-L1 Inhibitors Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 PD-1 and PD-L1 Inhibitors Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 PD-1 AND PD-L1 INHIBITORS INDUSTRY OVERVIEW
2.1 Global PD-1 and PD-L1 Inhibitors Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 PD-1 and PD-L1 Inhibitors Global Import Market Analysis
2.1.2 PD-1 and PD-L1 Inhibitors Global Export Market Analysis
2.1.3 PD-1 and PD-L1 Inhibitors Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 K Drugs
2.2.2 O Drugs
2.2.3 T Drugs
2.2.4 B Drugs
2.2.5 I Drugs
2.3 Market Analysis by Application
2.3.1 Gastric Tumor
2.3.2 Colorectal Cancer
2.3.3 Hodgkin'S Lymphoma
2.3.4 Non-Small Cell Lung Cancer
2.3.5 Urothelial Carcinoma
2.3.6 Renal Cell Carcinoma
2.3.7 Hepatoma
2.3.8 Other
2.4 Global PD-1 and PD-L1 Inhibitors Revenue, Sales and Market Share by Manufacturer
2.4.1 Global PD-1 and PD-L1 Inhibitors Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global PD-1 and PD-L1 Inhibitors Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 PD-1 and PD-L1 Inhibitors Manufacturer Market Share
2.4.5 Top 10 PD-1 and PD-L1 Inhibitors Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
2.4.7 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 PD-1 and PD-L1 Inhibitors Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): PD-1 and PD-L1 Inhibitors Industry Impact
2.7.1 How the Covid-19 is Affecting the PD-1 and PD-L1 Inhibitors Industry
2.7.2 PD-1 and PD-L1 Inhibitors Business Impact Assessment - Covid-19
2.7.3 Market Trends and PD-1 and PD-L1 Inhibitors Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region
4.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2019)
4.3 Global PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America PD-1 and PD-L1 Inhibitors Market Size Detail
4.4.1 North America PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.4.2 North America PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe PD-1 and PD-L1 Inhibitors Market Size Detail
4.5.1 Europe PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.5.2 Europe PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan PD-1 and PD-L1 Inhibitors Market Size Detail
4.6.1 Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.6.2 Japan PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China PD-1 and PD-L1 Inhibitors Market Size Detail
4.7.1 China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.7.2 China PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SEGMENT BY TYPE
5.1 Global PD-1 and PD-L1 Inhibitors Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales and Market Share by Type (2015-2020)
5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2015-2020)
5.2 K Drugs Sales Growth Rate and Price
5.2.1 Global K Drugs Sales Growth Rate (2015-2020)
5.2.2 Global K Drugs Price (2015-2020)
5.3 O Drugs Sales Growth Rate and Price
5.3.1 Global O Drugs Sales Growth Rate (2015-2020)
5.3.2 Global O Drugs Price (2015-2020)
5.4 T Drugs Sales Growth Rate and Price
5.4.1 Global T Drugs Sales Growth Rate (2015-2020)
5.4.2 Global T Drugs Price (2015-2020)
5.5 B Drugs Sales Growth Rate and Price
5.5.1 Global B Drugs Sales Growth Rate (2015-2020)
5.5.2 Global B Drugs Price (2015-2020)
5.6 I Drugs Sales Growth Rate and Price
5.6.1 Global I Drugs Sales Growth Rate (2015-2020)
5.6.2 Global I Drugs Price (2015-2020)
6 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 and PD-L1 InhibitorsSales Market Share by Application (2015-2020)
6.2 Gastric Tumor Sales Growth Rate (2015-2020)
6.3 Colorectal Cancer Sales Growth Rate (2015-2020)
6.4 Hodgkin'S Lymphoma Sales Growth Rate (2015-2020)
6.5 Non-Small Cell Lung Cancer Sales Growth Rate (2015-2020)
6.6 Urothelial Carcinoma Sales Growth Rate (2015-2020)
6.7 Renal Cell Carcinoma Sales Growth Rate (2015-2020)
6.8 Hepatoma Sales Growth Rate (2015-2020)
6.9 Other Sales Growth Rate (2015-2020)
7 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET FORECAST
7.1 Global PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast
7.1.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate Forecast (2020-2025)
7.1.2 Global PD-1 and PD-L1 Inhibitors Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global PD-1 and PD-L1 Inhibitors Price and Trend Forecast (2020-2025)
7.2 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2020-2025)
7.2.1 North America PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast (2020-2025)
7.2.2 Europe PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast (2020-2025)
7.2.3 Japan PD-1 and PD-L1 Inhibitors Production, Revenue Forecast (2020-2025)
7.2.4 China PD-1 and PD-L1 Inhibitors Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF PD-1 AND PD-L1 INHIBITORS INDUSTRY KEY MANUFACTURERS
8.1 Merck
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Merck PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Merck News
8.2 Tesaro
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Tesaro PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Tesaro News
8.3 AstraZeneca
8.3.1 Company Details
8.3.2 Product Information
8.3.3 AstraZeneca PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 AstraZeneca News
8.4 Pfizer
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Pfizer PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Pfizer News
8.5 Biocad
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Biocad PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Biocad News
8.6 Roche
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Roche PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Roche News
8.7 Boehringer Ingelheim
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Boehringer Ingelheim PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Boehringer Ingelheim News
8.8 Novartis
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Novartis PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Novartis News
8.9 Bristol-Myers Squibb
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Bristol-Myers Squibb News
8.10 Johnson & Johnson
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Johnson & Johnson PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Johnson & Johnson News
8.11 Beigene
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Beigene PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Beigene News
8.12 ALPHAMAB ONCOLOGY
8.12.1 Company Details
8.12.2 Product Information
8.12.3 ALPHAMAB ONCOLOGY PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 ALPHAMAB ONCOLOGY News
8.13 CytomX
8.13.1 Company Details
8.13.2 Product Information
8.13.3 CytomX PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 CytomX News
8.14 Harbin Gloria Pharmaceuticals
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Harbin Gloria Pharmaceuticals PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Harbin Gloria Pharmaceuticals News
8.15 Genor Biopharma
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Genor Biopharma PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Genor Biopharma News
8.16 Innovent Biologics
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Innovent Biologics PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Innovent Biologics News
8.17 Shanghai Junshi Biosciences
8.17.1 Company Details
8.17.2 Product Information
8.17.3 Shanghai Junshi Biosciences PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.17.4 Main Business Overview
8.17.5 Shanghai Junshi Biosciences News
8.18 3D Medicines
8.18.1 Company Details
8.18.2 Product Information
8.18.3 3D Medicines PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.18.4 Main Business Overview
8.18.5 3D Medicines News
8.19 Zhaoke Pharmaceutical
8.19.1 Company Details
8.19.2 Product Information
8.19.3 Zhaoke Pharmaceutical PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.19.4 Main Business Overview
8.19.5 Zhaoke Pharmaceutical News
8.20 Jiangsu Hengrui Medicine
8.20.1 Company Details
8.20.2 Product Information
8.20.3 Jiangsu Hengrui Medicine PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.20.4 Main Business Overview
8.20.5 Jiangsu Hengrui Medicine News
8.21 WuXi AppTec
8.21.1 Company Details
8.21.2 Product Information
8.21.3 WuXi AppTec PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.21.4 Main Business Overview
8.21.5 WuXi AppTec News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
1 SCOPE OF THE STUDY
1.1 PD-1 and PD-L1 Inhibitors Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 PD-1 AND PD-L1 INHIBITORS INDUSTRY OVERVIEW
2.1 Global PD-1 and PD-L1 Inhibitors Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 PD-1 and PD-L1 Inhibitors Global Import Market Analysis
2.1.2 PD-1 and PD-L1 Inhibitors Global Export Market Analysis
2.1.3 PD-1 and PD-L1 Inhibitors Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 K Drugs
2.2.2 O Drugs
2.2.3 T Drugs
2.2.4 B Drugs
2.2.5 I Drugs
2.3 Market Analysis by Application
2.3.1 Gastric Tumor
2.3.2 Colorectal Cancer
2.3.3 Hodgkin'S Lymphoma
2.3.4 Non-Small Cell Lung Cancer
2.3.5 Urothelial Carcinoma
2.3.6 Renal Cell Carcinoma
2.3.7 Hepatoma
2.3.8 Other
2.4 Global PD-1 and PD-L1 Inhibitors Revenue, Sales and Market Share by Manufacturer
2.4.1 Global PD-1 and PD-L1 Inhibitors Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global PD-1 and PD-L1 Inhibitors Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 PD-1 and PD-L1 Inhibitors Manufacturer Market Share
2.4.5 Top 10 PD-1 and PD-L1 Inhibitors Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
2.4.7 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 PD-1 and PD-L1 Inhibitors Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): PD-1 and PD-L1 Inhibitors Industry Impact
2.7.1 How the Covid-19 is Affecting the PD-1 and PD-L1 Inhibitors Industry
2.7.2 PD-1 and PD-L1 Inhibitors Business Impact Assessment - Covid-19
2.7.3 Market Trends and PD-1 and PD-L1 Inhibitors Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region
4.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2019)
4.3 Global PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America PD-1 and PD-L1 Inhibitors Market Size Detail
4.4.1 North America PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.4.2 North America PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe PD-1 and PD-L1 Inhibitors Market Size Detail
4.5.1 Europe PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.5.2 Europe PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan PD-1 and PD-L1 Inhibitors Market Size Detail
4.6.1 Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.6.2 Japan PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China PD-1 and PD-L1 Inhibitors Market Size Detail
4.7.1 China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020)
4.7.2 China PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SEGMENT BY TYPE
5.1 Global PD-1 and PD-L1 Inhibitors Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales and Market Share by Type (2015-2020)
5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2015-2020)
5.2 K Drugs Sales Growth Rate and Price
5.2.1 Global K Drugs Sales Growth Rate (2015-2020)
5.2.2 Global K Drugs Price (2015-2020)
5.3 O Drugs Sales Growth Rate and Price
5.3.1 Global O Drugs Sales Growth Rate (2015-2020)
5.3.2 Global O Drugs Price (2015-2020)
5.4 T Drugs Sales Growth Rate and Price
5.4.1 Global T Drugs Sales Growth Rate (2015-2020)
5.4.2 Global T Drugs Price (2015-2020)
5.5 B Drugs Sales Growth Rate and Price
5.5.1 Global B Drugs Sales Growth Rate (2015-2020)
5.5.2 Global B Drugs Price (2015-2020)
5.6 I Drugs Sales Growth Rate and Price
5.6.1 Global I Drugs Sales Growth Rate (2015-2020)
5.6.2 Global I Drugs Price (2015-2020)
6 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 and PD-L1 InhibitorsSales Market Share by Application (2015-2020)
6.2 Gastric Tumor Sales Growth Rate (2015-2020)
6.3 Colorectal Cancer Sales Growth Rate (2015-2020)
6.4 Hodgkin'S Lymphoma Sales Growth Rate (2015-2020)
6.5 Non-Small Cell Lung Cancer Sales Growth Rate (2015-2020)
6.6 Urothelial Carcinoma Sales Growth Rate (2015-2020)
6.7 Renal Cell Carcinoma Sales Growth Rate (2015-2020)
6.8 Hepatoma Sales Growth Rate (2015-2020)
6.9 Other Sales Growth Rate (2015-2020)
7 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET FORECAST
7.1 Global PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast
7.1.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate Forecast (2020-2025)
7.1.2 Global PD-1 and PD-L1 Inhibitors Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global PD-1 and PD-L1 Inhibitors Price and Trend Forecast (2020-2025)
7.2 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2020-2025)
7.2.1 North America PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast (2020-2025)
7.2.2 Europe PD-1 and PD-L1 Inhibitors Sales, Revenue Forecast (2020-2025)
7.2.3 Japan PD-1 and PD-L1 Inhibitors Production, Revenue Forecast (2020-2025)
7.2.4 China PD-1 and PD-L1 Inhibitors Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF PD-1 AND PD-L1 INHIBITORS INDUSTRY KEY MANUFACTURERS
8.1 Merck
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Merck PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Merck News
8.2 Tesaro
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Tesaro PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Tesaro News
8.3 AstraZeneca
8.3.1 Company Details
8.3.2 Product Information
8.3.3 AstraZeneca PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 AstraZeneca News
8.4 Pfizer
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Pfizer PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Pfizer News
8.5 Biocad
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Biocad PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Biocad News
8.6 Roche
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Roche PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Roche News
8.7 Boehringer Ingelheim
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Boehringer Ingelheim PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Boehringer Ingelheim News
8.8 Novartis
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Novartis PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Novartis News
8.9 Bristol-Myers Squibb
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Bristol-Myers Squibb News
8.10 Johnson & Johnson
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Johnson & Johnson PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Johnson & Johnson News
8.11 Beigene
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Beigene PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Beigene News
8.12 ALPHAMAB ONCOLOGY
8.12.1 Company Details
8.12.2 Product Information
8.12.3 ALPHAMAB ONCOLOGY PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 ALPHAMAB ONCOLOGY News
8.13 CytomX
8.13.1 Company Details
8.13.2 Product Information
8.13.3 CytomX PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 CytomX News
8.14 Harbin Gloria Pharmaceuticals
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Harbin Gloria Pharmaceuticals PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Harbin Gloria Pharmaceuticals News
8.15 Genor Biopharma
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Genor Biopharma PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Genor Biopharma News
8.16 Innovent Biologics
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Innovent Biologics PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Innovent Biologics News
8.17 Shanghai Junshi Biosciences
8.17.1 Company Details
8.17.2 Product Information
8.17.3 Shanghai Junshi Biosciences PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.17.4 Main Business Overview
8.17.5 Shanghai Junshi Biosciences News
8.18 3D Medicines
8.18.1 Company Details
8.18.2 Product Information
8.18.3 3D Medicines PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.18.4 Main Business Overview
8.18.5 3D Medicines News
8.19 Zhaoke Pharmaceutical
8.19.1 Company Details
8.19.2 Product Information
8.19.3 Zhaoke Pharmaceutical PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.19.4 Main Business Overview
8.19.5 Zhaoke Pharmaceutical News
8.20 Jiangsu Hengrui Medicine
8.20.1 Company Details
8.20.2 Product Information
8.20.3 Jiangsu Hengrui Medicine PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.20.4 Main Business Overview
8.20.5 Jiangsu Hengrui Medicine News
8.21 WuXi AppTec
8.21.1 Company Details
8.21.2 Product Information
8.21.3 WuXi AppTec PD-1 and PD-L1 Inhibitors Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.21.4 Main Business Overview
8.21.5 WuXi AppTec News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
LIST OF TABLES AND FIGURES
Figure PD-1 and PD-L1 Inhibitors Picture
Figure Research Programs/Design for This Report
Figure Global PD-1 and PD-L1 Inhibitors Market by Regions (2019)
Table Global Market PD-1 and PD-L1 Inhibitors Comparison by Regions (M USD) 2019-2025
Table Global PD-1 and PD-L1 Inhibitors Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure K Drugs Picture
Figure O Drugs Picture
Figure T Drugs Picture
Figure B Drugs Picture
Figure I Drugs Picture
Table Global PD-1 and PD-L1 Inhibitors Sales by Application (2019-2025)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure Gastric Tumor Picture
Figure Colorectal Cancer Picture
Figure Hodgkin'S Lymphoma Picture
Figure Non-Small Cell Lung Cancer Picture
Figure Urothelial Carcinoma Picture
Figure Renal Cell Carcinoma Picture
Figure Hepatoma Picture
Figure Other Picture
Table Global PD-1 and PD-L1 Inhibitors Sales by Manufacturer (2018-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturer in 2019
Table Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2018-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Manufacturer in 2019
Table Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 PD-1 and PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure Top 10 PD-1 and PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
Table Key Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units) by Region (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2019)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2019)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2018
Table Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Region (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table Japan PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table China PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Table Global PD-1 and PD-L1 Inhibitors Revenue by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type in 2019
Figure Global K Drugs Sales Growth Rate (2015-2020)
Figure Global K Drugs Price (2015-2020)
Figure Global O Drugs Sales Growth Rate (2015-2020)
Figure Global O Drugs Price (2015-2020)
Figure Global T Drugs Sales Growth Rate (2015-2020)
Figure Global T Drugs Price (2015-2020)
Figure Global B Drugs Sales Growth Rate (2015-2020)
Figure Global B Drugs Price (2015-2020)
Figure Global I Drugs Sales Growth Rate (2015-2020)
Figure Global I Drugs Price (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales by Application (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure Global Gastric Tumor Sales Growth Rate (2015-2020)
Figure Global Colorectal Cancer Sales Growth Rate (2015-2020)
Figure Global Hodgkin'S Lymphoma Sales Growth Rate (2015-2020)
Figure Global Non-Small Cell Lung Cancer Sales Growth Rate (2015-2020)
Figure Global Urothelial Carcinoma Sales Growth Rate (2015-2020)
Figure Global Renal Cell Carcinoma Sales Growth Rate (2015-2020)
Figure Global Hepatoma Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Price and Trend Forecast (2020-2025)
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units) Forecast by Region (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Production Market Share Forecast by Region (2020-2025)
Figure North America PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure China PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Merck Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Merck
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Tesaro Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Tesaro
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Tesaro PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Tesaro Main Business
Table Tesaro Recent Development
Table AstraZeneca Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of AstraZeneca
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Pfizer Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Pfizer
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Biocad Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Biocad
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocad PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Biocad Main Business
Table Biocad Recent Development
Table Roche Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Roche
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Boehringer Ingelheim Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Boehringer Ingelheim
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Boehringer Ingelheim PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Novartis Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Novartis
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Bristol-Myers Squibb
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Johnson & Johnson Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Johnson & Johnson
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Beigene Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Beigene
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Beigene PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Beigene Main Business
Table Beigene Recent Development
Table ALPHAMAB ONCOLOGY Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of ALPHAMAB ONCOLOGY
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure ALPHAMAB ONCOLOGY PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table ALPHAMAB ONCOLOGY Main Business
Table ALPHAMAB ONCOLOGY Recent Development
Table CytomX Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of CytomX
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure CytomX PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table CytomX Main Business
Table CytomX Recent Development
Table Harbin Gloria Pharmaceuticals Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Harbin Gloria Pharmaceuticals
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Harbin Gloria Pharmaceuticals PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Harbin Gloria Pharmaceuticals Main Business
Table Harbin Gloria Pharmaceuticals Recent Development
Table Genor Biopharma Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Genor Biopharma
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genor Biopharma PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Genor Biopharma Main Business
Table Genor Biopharma Recent Development
Table Innovent Biologics Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Innovent Biologics
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Innovent Biologics PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Innovent Biologics Main Business
Table Innovent Biologics Recent Development
Table Shanghai Junshi Biosciences Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Shanghai Junshi Biosciences
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Shanghai Junshi Biosciences PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Shanghai Junshi Biosciences Main Business
Table Shanghai Junshi Biosciences Recent Development
Table 3D Medicines Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of 3D Medicines
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure 3D Medicines PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table 3D Medicines Main Business
Table 3D Medicines Recent Development
Table Zhaoke Pharmaceutical Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Zhaoke Pharmaceutical
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Zhaoke Pharmaceutical PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Zhaoke Pharmaceutical Main Business
Table Zhaoke Pharmaceutical Recent Development
Table Jiangsu Hengrui Medicine Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Jiangsu Hengrui Medicine
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Jiangsu Hengrui Medicine PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Jiangsu Hengrui Medicine Main Business
Table Jiangsu Hengrui Medicine Recent Development
Table of Appendix
Figure PD-1 and PD-L1 Inhibitors Picture
Figure Research Programs/Design for This Report
Figure Global PD-1 and PD-L1 Inhibitors Market by Regions (2019)
Table Global Market PD-1 and PD-L1 Inhibitors Comparison by Regions (M USD) 2019-2025
Table Global PD-1 and PD-L1 Inhibitors Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure K Drugs Picture
Figure O Drugs Picture
Figure T Drugs Picture
Figure B Drugs Picture
Figure I Drugs Picture
Table Global PD-1 and PD-L1 Inhibitors Sales by Application (2019-2025)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure Gastric Tumor Picture
Figure Colorectal Cancer Picture
Figure Hodgkin'S Lymphoma Picture
Figure Non-Small Cell Lung Cancer Picture
Figure Urothelial Carcinoma Picture
Figure Renal Cell Carcinoma Picture
Figure Hepatoma Picture
Figure Other Picture
Table Global PD-1 and PD-L1 Inhibitors Sales by Manufacturer (2018-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturer in 2019
Table Global PD-1 and PD-L1 Inhibitors Revenue by Manufacturer (2018-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Manufacturer in 2019
Table Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 PD-1 and PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure Top 10 PD-1 and PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
Table Key Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units) by Region (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2019)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2019)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2018
Table Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Region (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table North America PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table Europe PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table Japan PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate (2015-2020)
Table China PD-1 and PD-L1 Inhibitors Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Table Global PD-1 and PD-L1 Inhibitors Revenue by Type (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type in 2019
Figure Global K Drugs Sales Growth Rate (2015-2020)
Figure Global K Drugs Price (2015-2020)
Figure Global O Drugs Sales Growth Rate (2015-2020)
Figure Global O Drugs Price (2015-2020)
Figure Global T Drugs Sales Growth Rate (2015-2020)
Figure Global T Drugs Price (2015-2020)
Figure Global B Drugs Sales Growth Rate (2015-2020)
Figure Global B Drugs Price (2015-2020)
Figure Global I Drugs Sales Growth Rate (2015-2020)
Figure Global I Drugs Price (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales by Application (2015-2020)
Table Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure Global Gastric Tumor Sales Growth Rate (2015-2020)
Figure Global Colorectal Cancer Sales Growth Rate (2015-2020)
Figure Global Hodgkin'S Lymphoma Sales Growth Rate (2015-2020)
Figure Global Non-Small Cell Lung Cancer Sales Growth Rate (2015-2020)
Figure Global Urothelial Carcinoma Sales Growth Rate (2015-2020)
Figure Global Renal Cell Carcinoma Sales Growth Rate (2015-2020)
Figure Global Hepatoma Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Price and Trend Forecast (2020-2025)
Table Global PD-1 and PD-L1 Inhibitors Sales (K Units) Forecast by Region (2020-2025)
Figure Global PD-1 and PD-L1 Inhibitors Production Market Share Forecast by Region (2020-2025)
Figure North America PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe PD-1 and PD-L1 Inhibitors Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China PD-1 and PD-L1 Inhibitors Production (K Units) Growth Rate Forecast (2020-2025)
Figure China PD-1 and PD-L1 Inhibitors Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Merck Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Merck
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Tesaro Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Tesaro
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Tesaro PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Tesaro Main Business
Table Tesaro Recent Development
Table AstraZeneca Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of AstraZeneca
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Pfizer Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Pfizer
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Biocad Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Biocad
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocad PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Biocad Main Business
Table Biocad Recent Development
Table Roche Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Roche
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Boehringer Ingelheim Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Boehringer Ingelheim
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Boehringer Ingelheim PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Novartis Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Novartis
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Bristol-Myers Squibb
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Johnson & Johnson Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Johnson & Johnson
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Beigene Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Beigene
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Beigene PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Beigene Main Business
Table Beigene Recent Development
Table ALPHAMAB ONCOLOGY Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of ALPHAMAB ONCOLOGY
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure ALPHAMAB ONCOLOGY PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table ALPHAMAB ONCOLOGY Main Business
Table ALPHAMAB ONCOLOGY Recent Development
Table CytomX Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of CytomX
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure CytomX PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table CytomX Main Business
Table CytomX Recent Development
Table Harbin Gloria Pharmaceuticals Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Harbin Gloria Pharmaceuticals
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Harbin Gloria Pharmaceuticals PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Harbin Gloria Pharmaceuticals Main Business
Table Harbin Gloria Pharmaceuticals Recent Development
Table Genor Biopharma Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Genor Biopharma
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genor Biopharma PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Genor Biopharma Main Business
Table Genor Biopharma Recent Development
Table Innovent Biologics Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Innovent Biologics
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Innovent Biologics PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Innovent Biologics Main Business
Table Innovent Biologics Recent Development
Table Shanghai Junshi Biosciences Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Shanghai Junshi Biosciences
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Shanghai Junshi Biosciences PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Shanghai Junshi Biosciences Main Business
Table Shanghai Junshi Biosciences Recent Development
Table 3D Medicines Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of 3D Medicines
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure 3D Medicines PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table 3D Medicines Main Business
Table 3D Medicines Recent Development
Table Zhaoke Pharmaceutical Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Zhaoke Pharmaceutical
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Zhaoke Pharmaceutical PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Zhaoke Pharmaceutical Main Business
Table Zhaoke Pharmaceutical Recent Development
Table Jiangsu Hengrui Medicine Company Profile
Figure PD-1 and PD-L1 Inhibitors Product Picture and Specifications of Jiangsu Hengrui Medicine
Table PD-1 and PD-L1 Inhibitors Production, Price, Revenue and Gross Margin of 2018-2020
Figure Jiangsu Hengrui Medicine PD-1 and PD-L1 Inhibitors Market Share (2018-2020)
Table Jiangsu Hengrui Medicine Main Business
Table Jiangsu Hengrui Medicine Recent Development
Table of Appendix
